Industry & Business

Takeda to Invest €25 Million at Grange Castle Site in Dublin

 Breaking News
  • Aramark’s Frank Gleeson Named European Industry Leader of the Year Frank Gleeson, president of Aramark Northern Europe, has been named the 2018 NACS European Industry Leader of the Year. The award, sponsored by Mondelēz International, was presented during the recent NACS Convenience Summit Europe in London. “I cannot think of a better leader to be recognised for this prestigious award. He has been one of the industry’s strongest advocates for [...]...
  • McAleer & Rushe Recognised at the Irish Construction Industry Awards Gala Northern Ireland-based developer and contractor McAleer & Rushe has been awarded the prize for ‘International Project of the Year’ at the Irish Construction Industry Awards for Global Student Accommodation’s 1000-bed Catherine House scheme in Portsmouth. The awards, now in their fifth year, recognise companies which demonstrate excellence and innovation in Ireland’s construction industry. McAleer & [...]...
  • Bord Bia’s 2018 Brexit Barometer Results The Minister for Agriculture, Food and the Marine Michael Creed TD has launched the Bord Bia 2018 Brexit Barometer, a comprehensive survey of 117 Irish food, drink and horticulture companies, representing 48% of the sector’s exporters to the United Kingdom. Over 100 senior industry representatives attended the launch in Bord Bia to hear the report findings. The purpose [...]...
  • College Group to Construct New €10 Million Biofuel Facility in County Meath College Group is to invest €10 million in building a new renewable energy facility producing biofuel from used cooking oil and animal fats in north County Meath. The investment is supported by the Irish government through Enterprise Ireland. The new 25 million litre purpose-built plant will be set on a 47.5 acre site and will [...]...
  • Irish Global Packaging Solutions Company Announces €27 Million Investment Zeus, the Irish-owned global packaging solutions company, has announced a €27 million investment in new premises in Dublin and the UK. The investment will also lead to the creation of 80 jobs. An investment of €15 million will see Zeus’ Dublin presence double in size to 250,000 sq ft, with the creation of 50 new jobs. Zeus [...]...

Takeda to Invest €25 Million at Grange Castle Site in Dublin

Takeda to Invest €25 Million at Grange Castle Site in Dublin
March 05
11:57 2018

Takeda Pharmaceutical Company is to create up to 70 new jobs and invest €25 million in the construction of a new regenerative medicine facility at its site in Grange Castle. The investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy. The investment will also create 70 temporary construction jobs.

The facility will be in commercial operation by 2021. This investment is supported by the Irish Government through IDA Ireland.

The largest pharmaceutical company in Japan, Takeda first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002 Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan. In 2017 Takeda also announced a €40 million investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio at Grange Castle.

Welcoming the announcement Pat Breen TD, Minister of State at the Department of Enterprise and Innovation, said: “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest growing sectors. Takeda’s decision to invest in Ireland is a great win and vote of confidence in Ireland and it builds on our ongoing expansion of the sector here. I’m delighted that this investment will bring a further 70 jobs to the company’s existing Clondalkin facility.”

Paul Keogh, Plant Director at Takeda Ireland Grange Castle, said that the additional investment in Ireland demonstrates the confidence and commitment Takeda has in its Irish operation. “To be chosen as the first site to introduce this new technology platform to our manufacturing network is very exciting. The nature of this product and its process will bring us closer to the patient than ever before which is a responsibility that we take very seriously. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site. The roles being created are in the areas of quality, manufacturing and engineering.”

Martin Shanahan, CEO of IDA Ireland, said: “Ireland is a globally recognised centre of excellence in Life sciences due to the country’s strong regulatory track record and talent availability. The investment by Takeda demonstrates their continued commitment to Ireland.”

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4